LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.48
+0.43 (8.51%)
At close: Jul 24, 2026, 4:00 PM EDT
5.38
-0.10 (-1.82%)
After-hours: Jul 24, 2026, 7:34 PM EDT
LENZ Therapeutics Stock Forecast
LENZ's stock price has decreased by -83.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, LENZ Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 483.94% higher than the current stock price, while the lowest is $12 (+118.98%) and the highest is $60 (+994.89%).
Price Target: $32 (+483.94%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $12 | Hold | Maintains | $12 | +118.98% | Jul 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 | Buy | Reiterates | $38 | +593.43% | Jul 7, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 6, 2026 |
| Citi | Citi | Buy Reiterates $26 → $20 | Buy | Reiterates | $26 → $20 | +264.96% | May 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 → $31 | Buy | Maintains | $29 → $31 | +465.69% | May 12, 2026 |
Financial Forecast
Revenue This Year
18.98M
from 19.09M
Decreased by -0.55%
Revenue Next Year
63.18M
from 18.98M
Increased by 232.82%
EPS This Year
-4.56
from -2.85
EPS Next Year
-3.51
from -4.56
EPS and Forward PE are based on non-GAAP adjusted numbers.